United States · FDA National Drug Code directory
Dabigatran Etexilate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0904-7253_869fd2f3-9357-4148-8b64-0cca96dd5f75
- Product NDC
- 0904-7253
- Form
- CAPSULE, COATED PELLETS
- Composition / generic term
- Dabigatran Etexilate
- Labeler
- Major Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250623
- Source listing expiry
- 20261231
Source-listed ingredients
- DABIGATRAN ETEXILATE MESYLATE — 75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (0904-7253-04) / 10 CAPSULE, COATED PELLETS in 1 BLISTER PACK (0904-7253-35) · 0904-7253-04
- 6 BLISTER PACK in 1 CARTON (0904-7253-68) / 10 CAPSULE, COATED PELLETS in 1 BLISTER PACK (0904-7253-35) · 0904-7253-68
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →